Form 4 for OCUL OCULAR THERAPEUTIX, INC

Accepted 2023-02-01 00:00:00 ET · period of report 2023-01-30 · accession 0001104659-23-009418 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-02-01	2023-01-30	OCUL	White Christopher G	Chief Business Off	A - Grant	$0.00	+44.4K	100.6K	+79%	$0
D	2023-02-01	2023-01-30	OCUL	White Christopher G	Chief Business Off	A - Grant	$0.00	+133.3K	133.3K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-01-30	A	A	44,444	$0.00	100,595	D	—	—	(F1) On January 30, 2023, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service to the Company, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter. (F2) Includes (i) 94,444 shares of common stock of the Company underlying unvested RSUs and (ii) 4,024 shares of the Company's common stock acquired under the 2014 Ocular Therapeutix, Inc. Employee Stock Purchase Plan on December 31, 2022.
2	Derivative	Stock Option (Right to Buy)	2023-01-30	A	A	133,333	$0.00	133,333	D	$3.88 · — to 2033-01-29	133,333 Common Stock	(F3) Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.